ADAG (Adagene) Forward P/E Multiple
Adagene is a non-cyclical biotech company whose resilience is based on grants and research results. Innovation hubs in the US and China are developing targeted therapies using AI. The company's forward P/E on the GURU.Markets system chart reflects expectation dynamics, where 0.00 determines this parameter level. SAFEbody patents and strict FDA control provide an intellectual moat.
Analytical breakdowns for Adagene
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ADAG - Company Profit|Projected Future Earnings Adagene|ADAG - P/E Multiple|Forward P/E Multiple Adagene|ADAG - Price to Net Income Growth Ratio|EV/EBITDA Multiple Adagene Inc|ADAG - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Adagene|ADAG - Earnings per share for the last 12 months|Quarterly EPS earnings growth adagene.com|ADAG - Earnings per share growth rate in current year|Earnings growth forecast for next year Adagene
Summary company analytics:Adagene Inc.
Forward P/E is calculated as the ratio of current market capitalization to projected net income over the next twelve months, measuring market expectations for capital efficiency. For Adagene (ADAG), this metric reflects the value of future cash flows secured by the unique SAFEbody platform and patents, allowing for an assessment of investment resilience through the business's forward P/E.
Competitors of Adagene (ADAG)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|Price to Future Earnings Ratio PGEN|PHAR (Pharming Group) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics Inc|Forward P/E Multiple UPB|Zenas Corp (ZBIO) - Forward Price to Earnings Multiple|Forward P/E Multiple IMNM (Immunome, Inc.)|gossamerbio.com (GOSS) - Projected Price to Earnings Ratio|KALV - Future Price to Earnings|SEPN (Septerna, Inc.) - Price to Future Earnings Ratio|PVLA: Forward P/E Multiple|Projected Price to Earnings Ratio Savara Pharma (SVRA)|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Forward P/E Multiple anaptysbio.com|Forward P/E Multiple ATXS|enGene Holdings Inc - Price to Future Earnings Ratio|Forward P/E Multiple RAPT (RAPT Therapeutics, Inc.)|Forward P/E Multiple Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics - Forward P/E Multiple|Forward Price to Earnings Multiple kyvernatx.com (KYTX)|Tiziana Life Sciences Ltd (TLSA) - Future Price to Earnings|Price to Expected Earnings Ratio CABA (Cabaletta Bio Inc.)|VTYX (Ventyx Bio) - Forward P/E Multiple|THTX: Future Price to Earnings Multiple|Forward P/E Multiple AVTX|Forward P/E Multiple eledon.com (ELDN)|Future Price to Earnings Agenus Inc. AGEN|Future Price to Earnings Multiple CLYM|ZURA - Future Price to Earnings|aTyr Pharmaceuticals (ATYR) - Projected Price to Earnings|IMA: Forward P/E Multiple|Shattuck Labs (STTK) - Forward P/E Multiple|Projected Price to Earnings EQ|CNTB: Future Price to Earnings Multiple|Forward P/E Multiple IMUX|Market Cap to Projected Earnings atarabio.com|Future Price to Earnings InflaRx IFRX|XFOR - Projected Price to Earnings|ACET - Future Price to Earnings|Celularity Inc. (CELU) - Projected Price to Earnings|INMB (INmune Bio Corp) - Projected Price to Earnings|Barinthus Biotherapeutics Corp (BRNS) - Forward P/E Multiple|Future Price to Earnings Kezar Life Sciences|Price to Future Earnings Ratio SABS (sabbiotherapeutics.com)|Forward P/E Multiple AKTX|ENLV - Projected Price to Earnings Ratio|Forward P/E Multiple QTTB (Q32 Bio)|Forward P/E Multiple GeoVax Corp GOVX|Edesa Biotech, Inc. - Forward P/E Multiple|IBIO (ibioinc.com) - Price to Future Earnings Ratio|CARM: Forward P/E Multiple|XTL Biopharmaceuticals Ltd (XTLB) - Forward P/E Multiple|BOLT (Bolt Biotherapeutics Inc.) - Forward P/E Multiple|HCWB - Forward Price to Earnings Multiple|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Future Price to Earnings Aditxt, Inc. ADTX|GRI: Price to Future Earnings Ratio|XORTX - Forward P/E Multiple|Projected Price to Earnings Ratio Vyome Therapeutics|REVB: Forward P/E Multiple|indaptusrx.com (INDP) - Forward P/E Multiple|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Forward P/E Multiple AFMD|Forward P/E Multiple allakos.com (ALLK)|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Forward Price to Earnings Multiple IGM Biosciences Inc.|ITOS - Future Price to Earnings|Price to Expected Earnings Ratio OCEA|TCBP: Forward P/E Multiple|Third Harmonic Bio Inc - Future Price to Earnings Multiple
